>Scientists turn ‘bad fat’ into ‘good fat’

>

Scientists say they have found a way to turn body fat into a better type of fat that burns off calories and weight.

The US Johns Hopkins team made the breakthrough in rats but believe the same could be done in humans, offering the hope of a new way to treat obesity.

Modifying the expression of a protein linked to appetite not only reduced the animals’ calorie intake and weight, but also transformed their fat composition.

“Bad” white fat became “good” brown fat, Cell Metabolism journal reports.

Brown fat is abundant in babies, which they use as a power source to generate body heat, expending calories at the same time.

But as we age our brown fat largely disappears and gets replaced by “bad” white fat, which typically sits as a spare tyre around the waist.

Experts have reasoned that stimulating the body to make more brown fat rather than white fat could be a helpful way to control weight and prevent obesity and its related health problems like type 2 diabetes.

Novel approach

Various teams have been searching for a way to do this, and Dr Sheng Bi and colleagues at the Johns Hopkins University School of Medicine believe they may have cracked it.

They designed an experiment to see if suppressing an appetite-stimulating protein called NPY would decrease body weight in rats.

When they silenced NPY in the brains of the rodents they found their appetite and food intake decreased.

Even when the rats were fed a very rich, high-fat diet they still managed to keep more weight off than rats who had fully functioning NPY.

The scientists then checked the fat composition of the rats and found an interesting change had occurred.

In the rats with silenced NPY expression, some of the bad white fat had been replaced with good brown fat.

The researchers are hopeful that it may be possible to achieve the same effect in people by injecting brown fat stem cells under the skin to burn white fat and stimulate weight loss.

Dr Bi said: “If we could get the human body to turn bad fat into good fat that burns calories instead of storing them, we could add a serious new tool to tackle the obesity epidemic.

“Only future research will tell us if that is possible.”

Dr Jeremy Tomlinson, an expert at the University of Birmingham’s Centre for Obesity Research, said: “This is exciting, novel and interesting.

“We will need a lot more work to tease this out, but it could offer a feasible way to develop new treatments for obesity.”
Source: BBC

>Nasal spray vaccine could prevent type 1 diabetes

>

A nasal spray vaccine currently being trialed in Australia could prevent the development of type 1 diabetes. Previous research showed that the nasal vaccine was successful in preventing the disease in mice, and now the results of a study involving 52 adults with early type 1 diabetes has provided encouraging evidence that it could also be effective in preventing the disease humans.

Type 1 diabetes occurs when the body’s immune system attacks and kills the insulin-producing beta cells in the pancreas. The subsequent lack of insulin leads to increased blood and urine glucose, which can result in heart disease, stroke, kidney failure, blindness and premature death if left untreated, with the most common treatment being the daily injection of insulin.

Although the 52 participants in the study had early type 1 diabetes and had evidence of immunity to insulin-producing beta cells in the pancreas, they were not yet at the stage of requiring insulin injections. For the study, the participants were given either the nasal vaccine or a placebo for 12 months.

When administered through the nasal passages, the insulin vaccine stimulates the immune system present in the mucosal linings and works to desensitize the whole immune system to insulin so that the immune system’s white blood cells are prevented from attacking insulin in the beta cells.

“The results showed that the vaccine allowed the immune system to restore immune tolerance to insulin,” said Professor Len Harrison of the Walter and Eliza Hall Institute in Melbourne, Australia. “When subsequently given insulin by injection, the participants who had received the nasal insulin vaccine were found to be desensitized to insulin.”

The researchers from the Walter and Eliza Hall Institute and the Royal Melbourne Hospital say the results of the study indicate they are on the right track to finding a vaccine for type 1 diabetes and the same approach could also be adapted to other autoimmune diseases.

“The nasal vaccine approach, if shown to be successful in human type 1 diabetes, could also be tested with different vaccines for the prevention of other autoimmune diseases such as rheumatoid arthritis and multiple sclerosis,” added Professor Harrison.

The Type 1 Diabetes Prevention Trial, which was previously known as the intranasal insulin trial, INIT II), began in 2006 and is now halfway through the testing phase. Following the encouraging results of the study, hopes are high a nasal vaccine for type 1 diabetes could be available in as little as two years.

Details of the research was published in the April 2011 issue of the journal Diabetes.

>Cool Your Brain For Better Sleep

>

You can’t sleep.  You’ve tried counting sheep, drinking warm milk, maybe even taking medications like Benadryl or sleeping pills.

Maybe next you should try cooling your brain.



According to research presented Monday at Sleep 2011, the annual meeting of the Associated Profession Sleep Societies, cooling the brain and can reduce the amount of time it takes people with insomnia to fall asleep — and increase the length of time they stay that way.

To achieve “frontal cerebral thermal transfer,” as the cooling is called, researchers Dr. Eric Nofzinger and Dr. Daniel Buysse of the Sleep Neuroimaging Research Program at the University of Pittsburgh School of Medicine outfitted 24 people —  12 with insomnia, and 12 without — with soft plastic caps.  The caps had tubes for circulating water at neutral, moderate or maximum “cooling intensity.”

The team observed how well participants slept with and without the caps, and at the different temperature levels.  Patients with insomnia who were treated at maximum cooling intensity for the whole night took about 13 minutes to fall asleep and slept 89% of the time that they were in bed, the researchers said.  That’s similar to the sleep enjoyed by healthy study subjects who didn’t have insomnia (who took 16 minutes to fall asleep and also slept 89% of the time).

The method is effective because it slows metabolism in the frontal cortex, according to the presenters.  Insomnia is associated with increased metabolism in that part of the brain; reduced metabolism, apparently, has the opposite effect.

In a press release, Nofzinger noted that only 25 percent of patients on sleeping pills said they were satisfied with the drugs, which can cause side effects and dependence.  The cooling caps may provide an effective, safe and natural alternative.  “We believe this has far-reaching implications for how insomnia can be managed in the future,” he said.
Source: LA Times

>Researchers Build the First Living Laser, Using Human Cells and Jellyfish Protein

>

Researchers at Harvard Medical School and Massachusetts General Hospital built a living laser partly to study interactions between electronic and biological systems, and partly out of sheer curiosity. The world’s first biological laser, made from a single living cell, could lead to better microscope imaging inside the body and even targeted light therapies, researchers say.

A single human cell engineered to express green fluorescent protein can be used to amplify photons into super-short pulses of laser light, the researchers say.

Lasers consist of a gain medium, the source of optical gain within the laser which absorbs external energy and excites atoms or molecules into a more energized state, inside an optical cavity. Most lasers use semiconductors, crystals or gases as a gain medium. In this case, the researchers used green fluorescent protein (GFP).

First, the researchers filled an inch-long cylinder with a GFP solution, and placed mirrors at each end. They pulsed it with light and confirmed the GFP solution could amplify the input energy into short pulses of laser emissions, according to anews release from Mass. General. This proved GFP could serve as the laser’s gain medium. Green fluorescent protein, isolated from jellyfish, will emit green light when it is exposed to blue light.

Then the team engineered human embryonic kidney cells to produce GFP, and placed a single cell between two mirrors, just 20 micrometers apart. The researchers flooded the cell with blue light, and the cell lit up. The mirrors served as the optical cavity, allowing light to bounce through the cell many times, amplifying it into a coherent green beam that was visible to the naked eye.

Living Laser Schematic: When a single biological cell genetically programmed to produce green fluorescent protein is placed inside an optical resonator consisting of two parallel mirrors separated by 20 µm (0.02 mm), the cell can generate green laser light.  Nature Photonics/Malte Gather, Wellman Center for Photomedicine, Massachusetts General Hospital

The cell’s spherical shape acted as a lens, refocusing the light and therefore requiring less energy for lasing than was necessary in the cylinder experiment. Best of all, the cells survived the lasing process, and were able to produce hundreds of pulses of laser light.

A living laser could have a wide range of medical uses, according to lead author Malte Gather at the Wellman Center for Photomedicine at Mass. General. They could be used to activate drugs using light, for instance, or for new forms of imaging — it is difficult for visible and UV light to penetrate very far inside the body. Eventually, living lasers could enable optical communications and computing inside the body, using living systems instead of electronics.

Sourcs: Popsci,Eurekalert, BBC

>Preventing Heart Attack Using Magnetic fields

>

Overly-viscous blood can damage blood vessels and lead to heart attacks. Therefore, people who are at risk of heart attacks take medications such as Aspirin, in order to thin their blood. Such drugs can have unpleasant side effects, however, and can only be taken a certain number of times per day. Prof. Rongjia Tao, a physicist from Philadelphia’s Temple University, now thinks he might have come up with a better way of thinning human blood – he subjects it to magnetic fields.

Tao had previously researched the use of magnetism for decreasing the viscosity of oil in engines and pipelines. Because blood contains iron, it turns out that it, too, becomes more fluid when magnetized.

In lab tests, Tao and Temple collaborator Ke “Colin” Huang subjected human blood samples to a magnetic field of 1.3 Telsa (roughly equivalent to an MRI) for approximately one minute. This polarized the red blood cells, which caused them to link together into short chains. These chains, because they are larger than single cells, tend to flow down the middle of blood vessels, instead of creating friction by moving against the inner walls. All told, he was able to decrease the viscosity of the samples by 20 to 30 percent.

The blood did return to its original viscosity once the magnetic field was removed, although it took several hours to do so. It is apparently safe to repeat the treatment over and over, however, as the function of the red blood cells does not appear to be affected.

“By selecting a suitable magnetic field strength and pulse duration, we will be able to control the size of the aggregated red-cell chains, hence to control the blood’s viscosity,” said Tao. “This method of magneto-rheology provides an effective way to control the blood viscosity within a selected range.”

More work is required, although Tao hopes to ultimately make the treatment available as a preventative therapy.

The research is being published in the journal Physical Review E.

Source: Gizmag

>Detecting and controlling seizures with brain implants

>

In the future, people who are prone to seizures may get an array of electrodes implanted in their brains. These electrodes would be capable of detecting the onset of a seizure, and then releasing medication to prevent it from happening. While it might sound far-fetched, scientists at the University of Pittsburgh have already demonstrated the technology on lab rats.

Multielectrode arrays (MEAs) are capable of recording or controlling the electrical activity in neurons, and are used in devices such as ear implants and pacemakers. The Pittsburgh team coated MEAs with the polymer Polypyrrole (PPy), which is known for its electrical conductivity. Mixed in with the PPy were anti-convulsive neurochemicals.

The coated MEAs were then placed on a rat’s brain, and electrically stimulated. This caused the neurochemicals to dissociate from the PPy, and diffuse into the adjacent regions of the brain. Testing indicated that after dissociation, the drugs still remained effective.

Similar technologies have involved implants with built-in drug reservoirs, although these would be larger than the coated MEAs, and could cause tissue damage.

“By directly loading a drug of interest onto an individual electrode site and using an electrical signal to trigger its release, we can precisely control the drug delivery site with ease,” said the study’s co-author, Prof. X Tracy Cui. “Additionally, our technology can be used for a combination of exogenous chemicals such as subtype-specific receptor antagonists, thus potentially allowing for more precise dissection of neural circuit function at the molecular level.”

The research was published this week in the Journal of Neural Engineering.

Source: Gizmag

>Nanofiber patch could regenerate dead areas of heart

>

When someone has a heart attack, the cells in the affected area of the heart die off, and the damage can’t be repaired. In the not-so-distant future, however, that may not be the case. Engineers from Rhode Island’s Brown University, working with colleagues in India, have created a carbon nanofiber patch that has been shown to regenerate heart cells. It is hoped that such patches could eventually be placed on the heart, like a Band-Aid, to regrow dead areas.

The patch itself is 22 millimeters long, 15 microns thick, has a scaffold-like structure, and can expand and contract like heart tissue. It is made from a government-approved polymer and carbon nanofibers. The fibers are said to be excellent conductors of electrons, and so are able to transmit the electrical impulses that the heart uses in order to maintain a steady beat.

The Brown team laid the patch on a glass substrate, then seeded its nanofibers with heart cells known as cardiomyocytes. After four hours, five times as many cells had colonized the nanofiber patch, than a control patch that consisted of the polymer only. This figure rose to six times the cell density, after five days. Additionally, after four days, the density of neurons on the nanofiber patch had doubled.

According to the engineers, the elasticity of the scaffolding and the electrical qualities of the nanofibers are what makes it such an ideal spawning ground for the cardiomyocytes and neurons.

There is still work to be done, however. The team now wants to alter the pattern of the scaffolding in order to better mimic the heart’s electrical current, along with placing a patch in a live subject to see how it handles the heart’s voltage and beat regime. They also want to confirm that the cardiomyocytes which grow on the patch are able to function in the same ways as regular heart cells.

The research, which was conducted in collaboration with the Indian Institute of Technology Kanpur, was recently published in the journal Acta Biomaterialia.

Source: Gizmag

>Paralyzed man regains voluntary leg movement with electrode array implant

>

In a move that gives cautious hope to the millions of people suffering some form of paralysis, a team of researchers from UCLA, Caltech and the University of Louisville has given a man rendered paralyzed from the chest down after a hit-and-run accident in 2006 the ability to stand and take his first tentative steps in four years. The team used a stimulating electrode array implanted into the man’s body to provide continual direct electrical stimulation to the lower part of the spinal cord that controls movement of the hips, knees, ankles and toes, to mimic the signals the brain usually sends to initiate movement.

Instead of bypassing the nervous system to directly stimulate the leg muscles, the electrical signals provided by the array stimulate the spinal cord’s own neural network so it can use the sensory input derived from the legs to direct muscle and joint movements. The stimulation therefore doesn’t induce movement, but taps into a network of spinal cord nerves that are capable of initiating movement on their own without the help of the brain, which then work together with cues from the legs to direct muscle movement.


The research team’s work builds on previous research at UCLA that showed animals with spinal-cord injuries could stand, balance, bear weight and take coordinated steps while the outermost part of the spinal canal – or epidural space – is stimulated.

Thanks to the breakthrough the test subject, 25 year old Rob Summers, is able to supply the muscular push required to stand up and remain standing for up to four minutes at a time. With periodic assistance, Summers is able to stand for up to an hour, and with the aid of a harness support and some assistance from a therapist he is able to take steps on a treadmill.

Prior to implantation with the epidural stimulating array, Summers, who suffered a complete motor injury at the C7/T1 level of the spinal cord, was unable to move even his toes. But after implantation he was able to not only stand and make repeated stepping motions on a treadmill with the assistance of a harness, but also regained the ability to voluntarily move his toes, ankles, knees, and hips on command. However, once the stimulation is turned off, Summers loses the voluntary control of his limbs.

Over time, Summers also experienced improvements in several types of autonomic function, including bladder and bowel control and temperature regulation. The researchers say these autonomic functions began to return before there was any sign of voluntary movement, which took around seven months after he began receiving epidural stimulation to emerge.

Although the researchers still aren’t yet fully sure how these autonomic functions were regained, the results indicate the treatment could help improve the quality of life of spinal cord injury sufferers other than those with the strength to undergo the rigorous physical training Summers did as part of his treatment. The researchers say the relief from secondary complications of complete spinal cord injury – including impairment or loss of bladder control, sphincter control and sexual response – could even prove to be ultimately as, or more important in terms of improving the quality of life of such patients.

While obviously encouraged by the results, the researchers are quick to point out that the study represents just one case and that there’s no way to tell how other patients may react. They also point out that Summers, who was an athlete in comparatively excellent physical condition before his accident, retained some sensation in his lower extremities after his injury indicating his spinal cord was not completely severed, which may have played a part in the level of success he was able to attain.

However, the researchers are hopeful that their work could one day provide some individuals suffering spinal cord injuries with the ability to stand independently, maintain balance and take effective steps through the use of a portable stimulation unit and the assistance of a walker. Additionally, the researchers believe the approach could potentially also help in the treatment of stroke, Parkinson’s, and other disorders affecting motor function.

The team has received approval from the FDA to test five spinal-cord injury patients and will next try and replicate their initial results with a patient that matches Summers in terms of age, injury, and physical ability. They will then turn to patients who have no sensation to see how that influences the outcome.

Interestingly, the device implanted into Summers is FDA-approved for back pain only and its use was meant only as a test to see if the researcher’s concepts would work. As a result, the researchers say the current implants have many limitations and that further advances in the technology should lead to better control of the standing and stepping process. They are also looking at whether it might be possible to move the array higher up on the spinal column to see if it could also be used to affect the arms and hands.

The UCLA, Caltech and University of Louisville researcher’s work is detailed in the paper, “Epidural stimulation of the lumbosacral spinal cord enables voluntary movement, standing, and assisted stepping in a paraplegic human,” which is published in The Lancet.

Source: Gizmag

>Surprisingly Simple Cure for Multiple Sclerosis By an Italian Doctor

>

Left: diagram from a medical text showing how MS affects the myelin sheathing of nerves. Right: MS lesions under a microscope.

An Italian doctor has been getting dramatic results with a new type of treatment for Multiple Sclerosis, or MS, which affects up to 2.5 million people worldwide. In an initial study, Dr. Paolo Zamboni took 65 patients with relapsing-remitting MS, performed a simple operation to unblock restricted bloodflow out of the brain – and two years after the surgery, 73% of the patients had no symptoms. Dr. Zamboni’s thinking could turn the current understanding of MS on its head, and offer many sufferers a complete cure.

Multiple sclerosis, or MS, has long been regarded as a life sentence of debilitating nerve degeneration. More common in females, the disease affects an estimated 2.5 million people around the world, causing physical and mental disabilities that can gradually destroy a patient’s quality of life.

It’s generally accepted that there’s no cure for MS, only treatments that mitigate the symptoms – but a new way of looking at the disease has opened the door to a simple treatment that is causing radical improvements in a small sample of sufferers.

Italian Dr. Paolo Zamboni has put forward the idea that many types of MS are actually caused by a blockage of the pathways that remove excess iron from the brain – and by simply clearing out a couple of major veins to reopen the blood flow, the root cause of the disease can be eliminated.

Dr. Zamboni’s revelations came as part of a very personal mission – to cure his wife as she began a downward spiral after diagnosis. Reading everything he could on the subject, Dr. Zamboni found a number of century-old sources citing excess iron as a possible cause of MS. It happened to dovetail with some research he had been doing previously on how a buildup of iron can damage blood vessels in the legs – could it be that a buildup of iron was somehow damaging blood vessels in the brain?

He immediately took to the ultrasound machine to see if the idea had any merit – and made a staggering discovery. More than 90% of people with MS have some sort of malformation or blockage in the veins that drain blood from the brain. Including, as it turned out, his wife.

He formed a hypothesis on how this could lead to MS: iron builds up in the brain, blocking and damaging these crucial blood vessels. As the vessels rupture, they allow both the iron itself, and immune cells from the bloodstream, to cross the blood-brain barrier into the cerebro-spinal fluid. Once the immune cells have direct access to the immune system, they begin to attack the myelin sheathing of the cerebral nerves – Multiple Sclerosis develops.

He named the problem Chronic Cerebro-Spinal Venous Insufficiency, or CCSVI.

Zamboni immediately scheduled his wife for a simple operation to unblock the veins – a catheter was threaded up through blood vessels in the groin area, all the way up to the effected area, and then a small balloon was inflated to clear out the blockage. It’s a standard and relatively risk-free operation – and the results were immediate. In the three years since the surgery, Dr. Zamboni’s wife has not had an attack.

Widening out his study, Dr. Zamboni then tried the same operation on a group of 65 MS-sufferers, identifying blood drainage blockages in the brain and unblocking them – and more than 73% of the patients are completely free of the symptoms of MS, two years after the operation.

In some cases, a balloon is not enough to fully open the vein channel, which collapses either as soon as the balloon is removed, or sometime later. In these cases, a metal stent can easily be used, which remains in place holding the vein open permanently.

Dr. Zamboni’s lucky find is yet to be accepted by the medical community, which is traditionally slow to accept revolutionary ideas. Still, most agree that while further study needs to be undertaken before this is looked upon as a cure for MS, the results thus far have been very positive.

Naturally, support groups for MS sufferers are buzzing with the news that a simple operation could free patients from what they have always been told would be a lifelong affliction, and further studies are being undertaken by researchers around the world hoping to confirm the link between CCSVI and MS, and open the door for the treatment to become available for sufferers worldwide.

It’s certainly a very exciting find for MS sufferers, as it represents a possible complete cure, as opposed to an ongoing treatment of symptoms. We wish Dr. Zamboni and the various teams looking further into this issue the best of luck.

Source: Gizmag Via The Globe and Mail.